authors
- Cho, Byoung Chul
- Juergens, Rosalyn
- Cheng, Ying
- de Castro, Gilberto
- Erman, Mustafa
- Bauman, Jessica R
- Takahashi, Toshiaki
- Schwarzenberger, Paul
- Li, Chengxiang
- Pietanza, M Catherine
- Yang, James Chih-Hsin
KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 15, 2022
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Cancer Research Journal